|
Ozmosis - Trusted Environment for Physicians |
|
Friday, 28 March 2008 |
|
Physicians now have a "trusted environment" where they learn the way they learn best - from each other - with launch of Ozmosis, a verified, physicians-only online information exchange dedicated to the discovery and sharing of medical knowledge and the improvement of patient care. |
|
Read more...
|
|
|
Doctors & Dentists Urged To Learn On The Net |
|
Thursday, 27 March 2008 |
|
Belfast company launches video based e-learning site for healthcare professionals in partnership with leading UK professional bodies. An innovative video based website that can help doctors, dentists and pharmacists polish up on their professional skills whenever and wherever they want has been launched by Northern Ireland based company, StreamOn. |
|
Read more...
|
|
|
New EU project to focus on membrane proteins with the aim of finding new treatments |
|
Tuesday, 25 March 2008 |
|
A new, EU-funded project will investigate membrane proteins with the aim of finding new treatments for a range of diseases. Membrane proteins are responsible for transporting chemicals and messages between the inside and outside of cells, and they are vital for every process in the human body. Defective membrane proteins have been implicated in a range of human diseases, including diabetes, heart disease, epilepsy, depression, osteoporosis, stomach ulcers and cataracts. |
|
Read more...
|
|
|
Integrating sex and gender differences in health research |
|
Wednesday, 19 March 2008 |
|
The EU-funded project GenderBasic has developed a number of recommendations for the improved integration of sex and gender differences in health-related research. Scientists must be aware of these differences at all stages of their studies, from the research content itself to the processes and methods employed in clinical trials, says project coordinator, Dr Ineke Klinge of the University of Maastricht in the Netherlands. |
|
Read more...
|
|
|
Public consultation in preparation of a legal proposal to combat counterfeit medicines for human use |
|
Tuesday, 18 March 2008 |
 Counterfeiting of medicinal products has become an increasing threat for patients, healthcare professionals and industry and a concern for EU and national policy-makers. The Directorate-General Enterprise and Industry is consulting all stakeholders and interested parties on key ideas for amending the regulatory framework for medicinal products in an effort to combat the counterfeiting of medicinal products. |
|
Read more...
|
|
|
FDA Takes Next Step in Establishing Overseas Presence |
|
Tuesday, 18 March 2008 |
 In an important development, the U.S. Food and Drug Administration has received approval from the U.S. State Department to establish eight full time permanent FDA positions at U.S. diplomatic posts in the People's Republic of China, pending authorization from the Chinese government. |
|
Read more...
|
|
|
ALERT project looks to ICT for drug safety |
|
Monday, 10 March 2008 |
|
A new EU-funded information and communication technology (ICT) project is tackling issues of safety in newly developed drugs. Over the next three and a half years, the ALERT ('Early detection of adverse drug events by integrative mining of clinical records and biomedical knowledge') project partners will work on an innovative computer system for a better and faster detection of adverse drug reactions (ADRs). |
|
Read more...
|
|
|
Tattooing is a more effective way of administering DNA vaccines than direct injection |
|
Tuesday, 04 March 2008 |
|
Tattooing is a more effective way of administering DNA vaccines than direct injection into muscle tissue, according to new research by German and Czech scientists. In DNA vaccination, a gene from a pathogen is injected directly into the host, which then produces the corresponding pathogen protein inside its own cells. This triggers a response from the host's immune system. Advantages of DNA vaccination include the fact that the vectors can be constructed quickly, and rapid and large scale vaccine production is much cheaper than for traditional vaccines. |
|
Read more...
|
|
|
Pharmathen's new Research and Development Centre in Pallini, Athens |
|
Monday, 03 March 2008 |
|
Pharmathen S.A announced the establishment of a new Research and Development Centre in Pallini, Athens. The new Research Centre will focus on developing Generic molecules and is expected to significantly reinforce Pharmathen's already excellent R&D capabilities. Pharmathen is one of the strongest generic developer in Europe and with the operation of the new facility the company's R&D activities will be further increased. |
|
Read more...
|
|
|
Labs are Vital(TM) Program Targets Science-Minded Students Through Facebook Social Media Network |
|
Tuesday, 26 February 2008 |
 In an effort to attract young people to the clinical laboratory profession, Labs Are Vital(TM), an initiative sponsored by Abbott, has tapped into Facebook, a popular social networking Web site, to reach out to more than four million students with an interest in life sciences. |
|
Read more...
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 51 - 60 of 124 |
news
European Commission - Pharmaceuticals
US Food and Drug Administration 
